Deutsch Intern
Chair for Drug Formulation and Delivery

Review on IFN drugs

02/24/2022

Congratulations to Niklas Hauptstein & team for their review ”Bioconjugation strategies and clinical implications of Interferon-bioconjugates“, published in the European Journal of Pharmaceutics and Biopharmaceutics. The article reviews available IFN drugs, their field and route of application, while also outlining available and future strategies for bioconjugation to further optimize pharmaceutical and clinical performances of all three available IFN classes.

https://www.sciencedirect.com/science/article/abs/pii/S0939641122000273

 

Reprinted with permission from Niklas Hauptstein, Lorenz Meinel, Tessa Lühmann,

Bioconjugation strategies and clinical implications of Interferon-bioconjugates,

European Journal of Pharmaceutics and Biopharmaceutics,

Copyright 2022, with permission from Elsevier/European Journal of Pharmaceutics and Biopharmaceutics

Back